Regenxbio Inc（RGNX）价格预测

$7.170

-0.223 (-3.11%)收盘时

价格预测

1-Day Price Prediction

+0.06%

1-Week Prediction

-1.75%

1-Month Prediction

—

2026 Prediction

—

2030 Prediction

—

在 App 中打开以解锁更长周期的预测。

Loading chart…

RGNX 相似图表分析预测

Alphio's RGNX stock price prediction model matches the current Regenxbio Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $7.17 (+0.06%). The 1-week path is $7.04 (-1.75%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

该买入 Regenxbio Inc 股票吗？

Regenxbio Inc (RGNX) is a good buy right now due to its recent positive developments in clinical trials and strong insider buying activity. The current price is $6.925, significantly lower than the analyst price targets of $21 and $22, indicating substantial upside potential. Additionally, the company has a gross margin of 99.04% in Q2 2026, showcasing strong profitability potential despite recent volatility. The main risk is the clinical hold on RGX-121, which has led to a downgrade in some analyst targets, but the overall sentiment remains bullish due to the promising RGX-202 trial results.

RGNX 股价于 Wednesday 收于 $7.17，此前下跌 -3.11%

Regenxbio Inc (RGNX) last closed at $7.17, gaining +0.00%. These facts feed the 1-day and 1-week RGNX price prediction above.

分析师一致预期

Regenxbio Inc（RGNX）：买入 5、持有 0、卖出 0。展望：Strong Buy。

Sell / Buy

Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.

Strong buy

Sell

Buy

预测驱动因素

Regenxbio Inc（RGNX）的预测驱动因素综合了相似的图表形态、季节性与移动平均线。

Similar patterns

Positive

Bullish

Seasonality

Negative

Bearish

SMA 20

Negative

Bearish

SMA 200

Negative

Bearish

相似图表形态

近期走势与 RGNX 最接近的股票，按相似度排序。

FLNC

91.25%

+3.35%

WAFD

91.10%

-4.03%

SMCI

90.30%

+3.06%

CVBF

90.27%

-8.08%

CMCSA

90.12%

-2.56%

RGNX 季节性分析

Historically the probability of a positive October return for RGNX is 37.10%. December offers the highest probability of a positive month at 51.16%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.

Loading chart…